Improving patient quality of life
With demonstrated clinical development and commercialization expertise, VIVUS is dedicated to addressing the therapeutic needs of patients with serious medical conditions and life-limiting diseases.
Our growing portfolio of products
PANCREAZE® for Exocrine Pancreatic Insufficiency (EPI)
Exocrine pancreatic insufficiency (EPI) is a condition that results from a deficiency in the production and/or secretion of pancreatic enzymes and can lead to chronic diarrhea, significant weight loss and malnutrition. While there is no cure for EPI, PANCREAZE, a pancreatic enzyme replacement therapy, is an effective therapy for managing this chronic disease.
Latest Press Releases
October 30, 2024
VIVUS & UpScriptHealth Announce Launch of ChooseQ.online for Access to Advanced Weight Management Solutions Collaborative Telehealth Platform
October 28, 2024
VIVUS Shares Significant Regulatory Update on QSYMIA
October 23, 2024
VIVUS Announces Labeling Update
VIVUS Locations and Contact Information
To access our corporate contact directories please select from:
Helpful Links and Resources
LOCATIONS
ABOUT VIVUS